Literature DB >> 1220975

R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness.

G Atassi, H J Tagnon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1220975     DOI： 10.1016/0014-2964(75)90092-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).

Authors:  Desirée Hao; Jinee D Rizzo; Stephanie Stringer; Rodney V Moore; Jennifer Marty; Daniel L Dexter; Gina L Mangold; James B Camden; Daniel D Von Hoff; Steven D Weitman
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

3.  Ineffectiveness of inicarone, a fibrinolytic agent, alone or in combination with chemotherapeutic agents on spontaneously metastasizing murine tumours.

Authors:  P Dumont; G Atassi; R De Jager
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

4.  Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans.

Authors:  L C Davidse; W Flach
Journal:  J Cell Biol       Date:  1977-01       Impact factor: 10.539
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.